Best hospitals in the world for treating liver disease: A 2026 evidence review

The best hospitals in the world for treating liver disease are concentrated in major academic and transplant centers across North America, Europe, and Asia. The 2026 Newsweek and Statista specialized gastroenterology ranking places Mayo Clinic in Rochester first, followed by Cleveland Clinic and Massachusetts General Hospital, with Asan Medical Center and Samsung Medical Center also in the top five. 1 These rankings are a starting point rather than a guarantee of an individual medical outcome.

How the international comparison was developed

Newsweek and Statista’s 2026 specialized-hospital assessment identifies leading institutions in gastroenterology, a field that includes many liver conditions. The published top 25 includes hospitals in the United States, South Korea, the United Kingdom, Italy, Germany, Brazil, Canada, Spain, and France. The list places Mayo Clinic in Rochester at number one, Cleveland Clinic at number two, Massachusetts General Hospital at number three, and Asan Medical Center at number four. 1 Gastroenterology ranking alone does not measure every transplant-specific outcome.

Leading hospitals in the United States

The Newsweek list also ranks Johns Hopkins Hospital sixth, Mount Sinai Hospital seventh, UCSF Medical Center thirteenth, Cedars-Sinai Medical Center fourteenth, and Mayo Clinic Hospital in Phoenix nineteenth. 1 Institutional information supplied for these centers describes different areas of concentration: Cleveland Clinic is recognized for hepatology and liver transplantation, Mount Sinai for transplant activity and liver research, Massachusetts General for complex liver disease and liver cancer, Johns Hopkins for comprehensive liver care, UCSF for cirrhosis and viral hepatitis research, and Cedars-Sinai for transplant services and clinical trials. 10

• Mayo Clinic, Rochester: first in the specialized gastroenterology ranking.
• Cleveland Clinic: hepatology and transplantation expertise.
• Mount Sinai: complex transplant surgery and research.
• Massachusetts General Hospital: multidisciplinary liver disease and cancer care.
• Johns Hopkins and UCSF: comprehensive care, diagnostics, and research programs.

Important centers in Europe and Asia

King’s College Hospital in London ranks ninth in the Newsweek gastroenterology table and is described as a major European liver-disease center. 1 Asan Medical Center in Seoul ranks fourth and is widely associated in the supplied research with living-donor liver transplantation. The Chinese University of Hong Kong’s Faculty of Medicine reported that U.S. News & World Report ranked it second globally in gastroenterology and hepatology in 2026, while also placing it first in Asia for that discipline. 2

Other internationally listed institutions include the University of Tokyo Hospital, which is identified in the research as a contributor to liver oncology and surgical research, and Catholic University of Korea Seoul St. Mary’s Hospital, which ranks twelfth in the Newsweek specialty table. 1 Acibadem describes a hepatobiliary program using advanced diagnostics and multidisciplinary expertise for complex biliary and transplantation cases, although institutional descriptions should be assessed alongside independent outcome data. 7

Transplant outcomes require separate evaluation

A hospital with a strong gastroenterology ranking is not automatically the strongest choice for every transplant candidate. The supplied transplant data illustrate why program-specific measures matter. UF Health Shands reported a 99.6% one-year liver-transplant survival rate and stated that its program had received all 15 bars in the Scientific Registry of Transplant Recipients’ five-tier assessment. 3 UC Davis reported outcomes above national expectations for transplanted-organ survival, waiting-list survival, and time to transplantation. 4

Pediatric and complex liver disease expertise

Montefiore Einstein describes an internationally focused liver-transplant program serving children and adults with acute or chronic liver disease and liver cancer. It reports 100% three-year survival among pediatric and adult recipients of living-donor liver transplants, the highest three-year survival rate in New York State for adult deceased-donor recipients, and 100% one-year survival for adult liver-heart and pediatric kidney-liver transplant groups. 5 These figures are institution-reported and may apply to specific patient groups rather than all cases.

King’s College Hospital Dubai reported eight completed pediatric liver transplants, including split-liver, auxiliary, living-donor, and deceased-donor procedures. The program treats conditions such as acute liver failure, metabolic liver disease, and congenital disorders, using specialists in hepatology, transplant surgery, pediatrics, intensive care, anesthesia, and rehabilitation. 8 The number of procedures alone should not be treated as a direct comparison with long-established national programs.

Questions to assess before choosing a center

Selection depends on diagnosis, urgency, age, transplant eligibility, donor circumstances, cancer stage, previous operations, and the need for pediatric or multi-organ care. Accreditation and outcome oversight are also important. The 2026 Newsweek hospital methodology incorporates medical recommendations, hospital quality measures, patient-experience data, and patient-reported outcomes, while its specialized-care framework includes safety indicators, accreditations, and CMS measures. 9

• Ask whether the center treats the specific liver condition, not only general digestive disease.
• Request risk-adjusted transplant survival, waiting-list survival, and complication data.
• Clarify eligibility rules, donor assessment, intensive-care capacity, and long-term follow-up.
• Confirm how liver cancer, biliary disease, viral hepatitis, cirrhosis, and transplantation are coordinated.
• Review travel, language, medical-record transfer, and continuity-of-care requirements.

Risks, limitations, and international care realities

Published rankings and hospital claims have limitations. A specialty ranking may emphasize reputation and broad quality indicators, whereas transplant registries focus on defined outcomes and reporting periods. Patient risk varies with disease severity, age, cancer, organ availability, donor type, and other clinical factors. In India, the supplied 2026 comparison gives an indicative planning range of approximately US$25,000 to US$55,000 for many living-donor liver transplants and estimates one-year survival of about 90% to 95% for lower-risk, well-selected adults at experienced centers. 6

International treatment also involves regulatory review, visa and travel logistics, donor safeguards, infection control, medical-record coordination, and follow-up after returning home. The India source estimates five to fourteen days for selected non-transplant procedures and six to ten weeks for transplantation, while noting that final plans vary by diagnosis and complexity. 6 These practical constraints, together with eligibility and ongoing medication or surveillance needs, make a specialist consultation and independent review of current program data essential.

Sources

1. Newsweek and Statista, World’s Best Specialized Hospitals 2026, Gastroenterology
2. CU Medicine, CU Medicine Ranked World No. 2 in Gastroenterology & Hepatology
3. Daily Transplant News, UF Health Shands liver and lung transplant programs
4. UC Davis Health, national data on liver transplant outcomes
5. Montefiore Einstein, Liver Disease & Transplant Care
6. Afiya India, Best Hospitals in India for Liver Treatment 2026
7. Acibadem International, Liver Transplant and Biliary Sciences
8. Khaleej Times, King’s College Hospital Dubai pediatric liver transplant program
9. Newsweek and Statista, America’s Best Hospitals for Specialized Care 2026
10. Institutional liver-care sources listed in the supplied research data